These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 29253572)

  • 1. Silencing of secretory clusterin sensitizes NSCLC cells to V-ATPase inhibitors by downregulating survivin.
    Kim YS; Jin HO; Hong SE; Song JY; Hwang CS; Park IC
    Biochem Biophys Res Commun; 2018 Jan; 495(2):2004-2009. PubMed ID: 29253572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA interference-mediated secretory clusterin gene silencing inhibits proliferation and promotes apoptosis of human non-small cell lung cancer cells.
    Yan Y; Luo K; Zhang H; Chai W
    Hepatogastroenterology; 2013; 60(121):70-5. PubMed ID: 22975582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effects of EGFR tyrosine kinase inhibitors and vATPase inhibitors in NSCLC cells.
    Jin HO; Hong SE; Kim CS; Park JA; Kim JH; Kim JY; Kim B; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
    Toxicol Appl Pharmacol; 2015 Aug; 287(1):17-25. PubMed ID: 25981168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide production by the vacuolar-type (H+)-ATPase inhibitors bafilomycin A1 and concanamycin A and its possible role in apoptosis in RAW 264.7 cells.
    Hong J; Nakano Y; Yokomakura A; Ishihara K; Kim S; Kang YS; Ohuchi K
    J Pharmacol Exp Ther; 2006 Nov; 319(2):672-81. PubMed ID: 16895977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression.
    Kim YS; Jin HO; Seo SK; Woo SH; Choe TB; An S; Hong SI; Lee SJ; Lee KH; Park IC
    Biochem Pharmacol; 2011 Aug; 82(3):216-26. PubMed ID: 21601561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. siRNA-directed clusterin silencing promotes cisplatin antitumor activity in human non-small cell lung cancer xenografts in immunodeficient mice.
    Zhang B; Liu ZM; Hao FG; Wang M
    Eur Rev Med Pharmacol Sci; 2014 Jun; 18(11):1595-601. PubMed ID: 24943969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secreted clusterin gene silencing enhances chemosensitivity of a549 cells to cisplatin through AKT and ERK1/2 pathways in vitro.
    Zhang B; Zhang K; Liu Z; Hao F; Wang M; Li X; Yin Z; Liang H
    Cell Physiol Biochem; 2014; 33(4):1162-75. PubMed ID: 24751980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.
    Zhong B; Sallman DA; Gilvary DL; Pernazza D; Sahakian E; Fritz D; Cheng JQ; Trougakos I; Wei S; Djeu JY
    Mol Cancer Ther; 2010 Jun; 9(6):1831-41. PubMed ID: 20501799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1 activates the P13K/AKT signaling pathway via upregulation of secretory clusterin.
    Ma X; Bai Y
    Mol Med Rep; 2012 Dec; 6(6):1433-7. PubMed ID: 23027041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations.
    Okamoto K; Okamoto I; Okamoto W; Tanaka K; Takezawa K; Kuwata K; Yamaguchi H; Nishio K; Nakagawa K
    Cancer Res; 2010 Dec; 70(24):10402-10. PubMed ID: 21159653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of secretory clusterin (sCLU) induces chemotherapy resistance in human gastric cancer cells by targeting miR-195-5p.
    Mu L; Yang F; Guo D; Li P; Zhang M
    Bioengineered; 2020 Dec; 11(1):472-483. PubMed ID: 32250192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periostin Contributes to Cisplatin Resistance in Human Non-Small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin.
    Hu W; Jin P; Liu W
    Cell Physiol Biochem; 2016; 38(3):1199-208. PubMed ID: 26982182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretory clusterin promotes oral cancer cell survival via inhibiting apoptosis by activation of autophagy in AMPK/mTOR/ULK1 dependent pathway.
    Naik PP; Mukhopadhyay S; Praharaj PP; Bhol CS; Panigrahi DP; Mahapatra KK; Patra S; Saha S; Panda AK; Panda K; Paul S; Aich P; Patra SK; Bhutia SK
    Life Sci; 2021 Jan; 264():118722. PubMed ID: 33160989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulating sCLU enhances the sensitivity of hepatocellular carcinoma cells to gemcitabine by activating the intrinsic apoptosis pathway.
    Xiu P; Xu Z; Liu F; Li Z; Li T; Zou F; Sun X; Li J
    Dig Dis Sci; 2014 Aug; 59(8):1798-809. PubMed ID: 24671452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. sCLU regulates cisplatin chemosensitivity of lung cancer cells in vivo.
    Ma G; Cai H; Gao L; Wang M; Wang H
    World J Surg Oncol; 2015 Feb; 13():80. PubMed ID: 25884382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small interfering RNA-mediated suppression of serum response factor, E2-promotor binding factor and survivin in non-small cell lung cancer cell lines by non-viral transfection.
    Walker T; Nolte A; Steger V; Makowiecki C; Mustafi M; Friedel G; Schlensak C; Wendel HP
    Eur J Cardiothorac Surg; 2013 Mar; 43(3):628-33; discussion 633-4. PubMed ID: 23152437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
    Zhang K; Li Y; Liu W; Gao X; Zhang K
    Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vacuolar H+ ATPase enhances sensitivity to tamoxifen via up-regulation of CHOP in breast cancer cells.
    Jin HO; Lee YH; Kim HA; Kim EK; Noh WC; Kim YS; Hwang CS; Kim JI; Chang YH; Hong SI; Hong YJ; Park IC; Lee JK
    Biochem Biophys Res Commun; 2013 Aug; 437(3):463-8. PubMed ID: 23838288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Clusterin Induces Apoptosis, Reduces Growth Ability and Invasion and Mediates Sensitivity to Chemotherapy in Human Osteosarcoma Cells.
    Wang X; Yu Y; Zang L; Zhang P; Ma J; Chen D
    Curr Pharm Biotechnol; 2020; 21(2):131-139. PubMed ID: 31433751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small interfering RNA targeted to secretory clusterin blocks tumor growth, motility, and invasion in breast cancer.
    Niu Z; Li X; Hu B; Li R; Wang L; Wu L; Wang X
    Acta Biochim Biophys Sin (Shanghai); 2012 Dec; 44(12):991-8. PubMed ID: 23099883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.